Executive Chairman David Schlanger of Progyny Inc (PGNY, Financial) has sold 71,272 shares of the company on March 27, 2024, according to a recent SEC filing. The transaction was executed at an average price of $37.8 per share, resulting in a total value of $2,694,083.6.
Progyny Inc (PGNY, Financial) is a company that specializes in fertility and family building benefits solutions in the United States. The company offers employer-sponsored fertility benefits for employees and their partners who are seeking to start a family. Progyny's services include access to a premier network of fertility specialists, smart cycle plans, and personalized guidance and support from Patient Care Advocates.
Over the past year, David Schlanger has sold a total of 1,060,000 shares of Progyny Inc and has not made any purchases of the stock. The insider transaction history for Progyny Inc shows a pattern of 41 insider sells and no insider buys over the past year.
On the day of the insider's recent sale, Progyny Inc shares were trading at $37.8, giving the company a market capitalization of $3.681 billion. The price-earnings ratio of the stock stands at 61.53, which is above the industry median of 25.89 but below the company's historical median price-earnings ratio.
The stock's price-to-GF-Value ratio is 0.55, with a GF Value of $68.67, indicating that Progyny Inc is significantly undervalued according to GuruFocus's intrinsic value estimate. The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
